

EN

Back



Denali Secures $275M Royalty Deal for Hunter Syndrome Drug

Stock NewsThemesDenali Secures $275M Royalty Deal for Hunter Syndrome Drug

Denali Secures $275M Royalty Deal for Hunter Syndrome Drug

Edgen Stock·Dec 24 2025, 17:28

Share to

Share to

Copy link

source:

[1] Denali announces $275m funding agreement with Royalty Pharma (https://www.pharmaceutical-technology.com/new ...)

Related News

Red Cat Stock Slides 1.1% as FCC Drone Ban Fails to Impress Investors

Dec 24 2025, 20:18

Red Cat Stock Slides 1.1% as FCC Drone Ban Fails to Impress Investors

Red Cat Holdings (RCAT) shares fell 1.1% on December 23 after an initial 5% gain, as investors weighed the benefits of a new FCC ban on foreign drones against the company's weak financials.

Costco Ownership Analysis Reveals 69% Institutional Control

Dec 24 2025, 19:34

Costco Ownership Analysis Reveals 69% Institutional Control

An analysis of Costco's (COST) ownership structure shows institutional investors control 69% of the company, highlighting their significant influence over the retail giant's stock.

CB&I Acquires Petrofac's UK Arm, Saving 3,000 Jobs

Dec 24 2025, 18:53

CB&I Acquires Petrofac's UK Arm, Saving 3,000 Jobs

Chicago Bridge & Iron Company (CB&I) has acquired Petrofac's Aberdeen-based engineering and operations arm, a move that saves approximately 3,000 UK jobs while avoiding Petrofac's estimated $707.9 million debt.